MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

(-)-(S)-Equol

CAS No. : 531-95-3

产品活性：(-)-(S)-Equol is a high affinity ligand for estrogen receptor β with a K_i of 0.73 nM.

研究领域：Vitamin D Related/Nuclear Receptor  |  Metabolic Enzyme/Protease

作用靶点：Estrogen Receptor/ERR  |  Endogenous Metabolite

结构分类：黄酮类  |  黄烷醇类  |  酚类  |  多酚类

In Vitro: (-)-(S)-Equol shows the greatest affinity for ERβ (Ki=0.73±0.2 nM), whereas its affinity for ERα (Ki=6.41±1 nM) is relatively poor. (-)-(S)-Equol inhibits the growth of LnCaP, DU145 and PC3 human prostate cancer cell lines. (-)-(S)-Equol causes cell cycle arrest in the G2/M phase in PC3 cells by down regulating cyclin B1 and CDK1 and upregulating CDK inhibitors (p21 and p27), as well as inducing apoptosis by upregulating Fas ligand (FasL) and the expression of pro-apoptotic Bim. (-)-(S)-Equol increases the expression of FOXO3a, decreases the expression of p-FOXO3a and enhances the nuclear stability of FOXO3a. (-)-(S)-Equol also decreases the expression of MDM2, which serves as an E3 ubiquitin ligase forp-FOXO3a, thus preventing p-FOXO3a degradation by the proteasome. (-)-(S)-Equol enantioselectively increases the survival of INS-1 cells presumably through activating PKA signaling. (-)-(S)-Equol might have applications as an anti-type 2 diabetic agent. In INS-1 pancreatic β-cells, (-)-(S)-Equol induces phosphorylation of cAMP-response element-binding protein at Ser 133, and induced cAMP-response element-mediated transcription.

In Vivo: (-)-(S)-Equol inhibits the tumor growth by 43.2% and 28.4% compared to the control on day 33, suggesting that the compound is not overtly toxic.

相关产品：Natural Product Library Plus  |  Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Natural Product Library  |  Anti-Cancer Compound Library  |  Human Endogenous Metabolite Compound Library  |  Anti-diabetic Compound Library  |  Medicine Food Homology Compound Library  |  Phenols Library  |  Traditional Chinese Medicine Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Flavonoids Library  |  Food-Sourced Compound Library   |  Anti-Cancer Natural Product Library  |  Human Metabolite Library  |  Nuclear Receptor Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  D-Valine-d₈  |  D-α-Hydroxyglutaric acid disodium  |  Nicotinamide N-oxide  |  Deoxycholic acid-d₅  |  Doxorubicin-¹³C,d₃ (TFA)  |  Palitantin  |  Estradiol hemihydrate  |  OP-1074  |  Adrenaline sulfate  |  Oleic acid-¹³C  |  Dextranase  |  H2S Donor 5a  |  Methylmalonic acid  |  Glycine, N-(aminoiminomethyl)-N-methyl-¹³C  |  Dihydroxyacetone phosphate  |  Sphingomyelin  |  (-)-Jasmonoyl-L-isoleucine  |  Octanoic acid-d₂  |  Vardenafil-d₅  |  N-Acetyllactosamine  |  D-Arabitol-¹³C  |  Imidazole  |  L-Tartaric acid diammonium  |  i-Inositol  |  Tryptophol  |  L-Aspartic acid  |  Indolelactic acid  |  6-Mercaptopurine-¹³C₂,¹⁵N  |  D-Sorbitol-d₈  |  Octanoic acid-d₃

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种*仅有化合物库，我们致力于为*科研客户提供前沿的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药 Patent 收录了MCE客户的科研成果；
•   专业团队跟踪新的制药及生命科学研究进展，为您提供*新的活性化合物；
•   与世界各大制药公司及*科研机构建立了长期的合作。